As an experienced forex trader, I always make fund safety my top priority when evaluating any broker or technology provider. With Leverate, I took extra care in assessing their regulatory claims and operational structure. According to the evidence I reviewed, Leverate presents a complex picture with notable red flags. While they claim ties to CySEC and reference a specific license number, the available information strongly suggests that their regulatory standing is highly questionable—essentially, Leverate appears to be operating as a “clone broker,” using the details of a properly regulated entity but not itself holding valid oversight. This is not a minor technicality: trust in regulatory protections only applies when a broker is genuinely under a competent authority. Moreover, recent reports indicate Leverate has been excluded from the CySEC Investor Compensation Fund, further diminishing any institutional safety net that individual traders might expect. In my view, protections such as segregated accounts, compensation funds, and formal dispute resolution—critical aspects of true regulation—are at serious risk when these regulatory relationships are unverified or misrepresented. For me, this means I would not consider my funds adequately safeguarded if entrusted to Leverate. In short, without authentic, verifiable regulatory oversight, there simply isn’t a reliable assurance of fund security with this provider, so I would exercise utmost caution.